TREACE MEDICAL CONCEPTS, INC. (TMCI) Insider Trading -- Recent Executive & Director Transactions

14 insiders reported 75 Form 4 transactions for TREACE MEDICAL CONCEPTS, INC. (TMCI) over the past 18 months (most recent 2026-06-12). Recent activity: Treace John T. (Chief Executive Officer) Buy 14,715 shares, Treace John T. (Chief Executive Officer) Buy 9,891 shares, Treace John T. (Chief Executive Officer) Buy 29,430 shares, Treace John T. (Chief Executive Officer) Buy 22,887 shares, Treace John T. (Chief Executive Officer) Buy 50,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-12Treace John T.Chief Executive OfficerBuy14,715$59,213
2026-06-12Treace John T.Chief Executive OfficerBuy9,891$39,982
2026-06-11Treace John T.Chief Executive OfficerBuy29,430$118,426
2026-06-11Treace John T.Chief Executive OfficerBuy22,887$92,541
2026-06-01Treace John T.Chief Executive OfficerBuy50,000$177,915
2026-05-19HAMILTON LAWRENCE WDirectorBuy30,000$0
2026-05-19BAKEWELL JOHN KDirectorBuy30,000$0
2026-05-19Kiernan Jane EDirectorBuy30,000$0
2026-05-19Berry Lance ADirectorBuy30,000$0
2026-05-19Jain DeeptiDirectorBuy30,000$0
2026-05-19Hanna BetsyDirectorBuy30,000$0
2026-05-14Treace John T.Chief Executive OfficerBuy43,000$93,478
2026-05-14Treace John T.Chief Executive OfficerBuy61,750$161,495
2026-05-14Treace John T.Chief Executive OfficerBuy49,013$120,533
2026-04-20Hair MarkChief Financial OfficerSell11,547$0
2026-04-03Hair MarkChief Financial OfficerBuy100,000$0
2026-03-11Elder Scot MichaelChief Legl & Comp Off, CorpSecSell175$0
2026-03-11Elder Scot MichaelChief Legl & Comp Off, CorpSecSell1,675$0
2026-03-11Scanlan Sean F.Chief Innovation OfficerSell401$0
2026-03-11Scanlan Sean F.Chief Innovation OfficerSell1,396$0
2026-03-11Hair MarkChief Financial OfficerSell964$0
2026-03-11Hair MarkChief Financial OfficerSell3,695$0
2026-03-11Treace John T.Chief Executive OfficerSell2,062$0
2026-03-11Treace John T.Chief Executive OfficerSell5,021$0
2026-02-11Scanlan Sean F.Chief Innovation OfficerBuy16,875$17,719

Source: SEC Form 4 filings · as of 2026-06-12